Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28519640 | 1.00 | TP53 (0.43) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL1444051 | 1.00 | TP53 (0.43) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL28390273 | 1.00 | TP53 (0.43) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL7949738 | 1.00 | TP53 (0.43) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL28916136 | 0.94 | TP53 (0.38) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL8980187 | 0.94 | TP53 (0.38) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL8980183 | 0.94 | TP53 (0.38) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL9741130 | 0.94 | TP53 (0.38) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL16111827 | 0.94 | TP53 (0.38) | TP53TSHRALDH1A1 | |
| Benzene SCHEMBL9741754 | 0.94 | TP53 (0.38) | TP53TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122707-B1 | METHOD FOR COUPLING A FIRST AROMATIC COMPOUND TO A SECOND AROMATIC COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-04-25 | — | — | EP | claimed |
| WO-2011031401-A2 | LITHIUM NON-FLUORINATED AND FLUORINATED PHENYL TRIFLUORO BORATE SALTS FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-03-17 | — | — | WO | claimed |
| WO-2026044522-A1 | PREPARATION METHOD FOR 4-(DIMETHOXYMETHYL-4-PIPERIDINE)PHENYLBORONIC ACID PINACOL ESTER | 上海再启生物技术有限公司 | 2026-03-05 | — | — | WO | disclosed |
| WO-2025049387-A2 | ETCHING COMPOSITIONS | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| EP-3080240-B1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MAT USA INC (US) | 2024-10-16 | — | — | EP | disclosed |
| US-11718616-B2 | JAK kinase inhibitor compounds for treatment of respiratory disease | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2023-08-08 | — | — | US | disclosed |
| CN-116344940-A | Electrolyte and battery comprising same | 珠海冠宇电池股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| US-20220306624-A1 | JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2022-09-29 | — | — | US | disclosed |
| CN-110573508-B | Fused imidazo-piperidine JAK inhibitor compounds | 施万生物制药研发IP有限责任公司 | 2022-07-05 | — | — | CN | disclosed |
| US-11299492-B2 | JAK kinase inhibitor compounds for treatment of respiratory disease | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2022-04-12 | — | — | US | disclosed |
| US-20220008428-A1 | FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2022-01-13 | — | — | US | disclosed |
| WO-2015089023-A1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2015-06-18 | — | — | WO | disclosed |
| US-20150159125-A1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2015-06-11 | — | — | US | disclosed |
| EP-2723701-A1 | PROCESSES FOR PREPARING PHOSPHORUS-CONTAINING ALPHA- AND BETA-AMINO ACIDS AND DERIVATIVES THEREOF | Diverchim (FR) | 2014-04-30 | — | — | EP | disclosed |
| US-20130303402-A1 | Detection and Molecular Weight Determination of Organic Vapors | Board of Supervisors of Louisiana State University and Agricultural and Mechinical College (US) | 2013-11-14 | — | — | US | disclosed |
| WO-2012175837-A1 | PROCESSES FOR PREPARING PHOSPHORUS-CONTAINING Α- AND Β-AMINO ACIDS AND DERIVATIVES THEREOF | DIVERCHIM (FR) | 2012-12-27 | — | — | WO | disclosed |
| US-20110217553-A1 | Frozen Ionic Liquid Microparticles and Nanoparticles, and Methods for their Synthesis and Use | U.S. DEPARTMENT OF ENERGY | 2011-09-08 | — | — | US | disclosed |
| WO-2011031401-A3 | LITHIUM NON-FLUORINATED AND FLUORINATED PHENYL TRIFLUORO BORATE SALTS FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011031401-A2 | LITHIUM NON-FLUORINATED AND FLUORINATED PHENYL TRIFLUORO BORATE SALTS FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011031401-A2 | LITHIUM NON-FLUORINATED AND FLUORINATED PHENYL TRIFLUORO BORATE SALTS FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299492-B2 | JAK kinase inhibitor compounds for treatment of respiratory disease | JAK1, JAK2, JAK3 | TP53 3675/4885TSHR 1978/4885ALDH1A1 2782/4885 |
| US-11718616-B2 | JAK kinase inhibitor compounds for treatment of respiratory disease | JAK1, JAK2, JAK3 | TP53 3675/4885TSHR 1978/4885ALDH1A1 2782/4885 |
| US-20220306624-A1 | JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE | JAK1, JAK2, JAK3 | TP53 3675/4885TSHR 1978/4885ALDH1A1 2782/4885 |
| US-20220008428-A1 | FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND | JAK1, JAK2, JAK3 | TP53 1198/4885TSHR 2139/4885ALDH1A1 2138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.